Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$0.66
-0.9%
$0.73
$0.56
$3.04
$3.87M0.1926,303 shs12,562 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.09
-4.5%
$0.08
$0.06
$0.24
$1.22M0.497,500 shs10,325 shs
Pheton Holdings Ltd stock logo
PTHL
Pheton
$0.58
-10.9%
$14.09
$0.55
$32.00
$4.25MN/A3.50 million shs691,381 shs
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
$7.21
+0.8%
$8.27
$5.01
$54.95
$4.21M1.444,502 shs3,192 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-0.91%-4.80%-14.28%-25.65%-65.89%
Dynatronics Co. stock logo
DYNT
Dynatronics
-4.54%+2.89%+18.75%+8.94%-45.53%
Pheton Holdings Ltd stock logo
PTHL
Pheton
-10.16%-19.57%-97.41%-89.35%+57,499,900.00%
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
+0.84%-0.07%-14.98%-14.88%-58.80%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.4171 of 5 stars
0.03.00.00.01.80.00.6
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/AN/AN/AN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
0.997 of 5 stars
0.04.00.00.02.30.80.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.00
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
0.00
N/AN/AN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/A$4.05 per shareN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.04N/AN/A$0.57 per share0.16
Pheton Holdings Ltd stock logo
PTHL
Pheton
$450K8.41N/AN/A$0.94 per share0.61
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
N/AN/AN/AN/A$4.34 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-$17.57M-$3.00N/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%9/22/2025 (Estimated)
Pheton Holdings Ltd stock logo
PTHL
Pheton
-$660KN/A0.00N/AN/AN/AN/AN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
-$8.96M-$41.45N/AN/AN/AN/A-210.50%-99.41%11/6/2025 (Estimated)

Latest DYNT, QNRX, PTHL, and CHEK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
-$6.83-$6.28+$0.55-$6.28N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
12.39
12.17
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
N/A
1.96
1.96

Institutional Ownership

CompanyInstitutional Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
1.07%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
8.63%

Insider Ownership

CompanyInsider Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.48%
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
13.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
Check-Cap Ltd. stock logo
CHEK
Check-Cap
805.85 million5.82 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20013.18 million8.11 millionNot Optionable
Pheton Holdings Ltd stock logo
PTHL
Pheton
116.58 millionN/AN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
4590,000509,000Not Optionable

Recent News About These Companies

Quoin (QNRX) Q2 Loss Beats Estimates
Quoin Pharmaceuticals Provides Product Portfolio Update
Quoin Pharmaceuticals, Ltd. (QNRX) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Check-Cap stock logo

Check-Cap NASDAQ:CHEK

$0.66 -0.01 (-0.91%)
Closing price 08/19/2025 03:45 PM Eastern
Extended Trading
$0.66 0.00 (0.00%)
As of 08/19/2025 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.09 0.00 (-4.54%)
As of 08/19/2025 11:41 AM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Pheton stock logo

Pheton NASDAQ:PTHL

$0.57 -0.07 (-10.85%)
Closing price 08/19/2025 04:00 PM Eastern
Extended Trading
$0.60 +0.03 (+4.35%)
As of 08/19/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

Quoin Pharmaceuticals stock logo

Quoin Pharmaceuticals NASDAQ:QNRX

$7.21 +0.06 (+0.84%)
Closing price 08/19/2025 03:35 PM Eastern
Extended Trading
$7.16 -0.05 (-0.69%)
As of 08/19/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.